Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 238 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2450 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120908 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120914 |
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-08-20 | 2020-12-17 | 122685 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2023-06-08 | 2023-06-21 | 194077 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195459 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-20 | 2023-10-03 | 199284 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-10-19 | 2024-01-11 | 207497 |
TEVA-FUROSEMIDE | 40MG | TABLET | Actual shortage | 2024-02-08 | 2024-02-15 | 218940 |
TEVA-FUROSEMIDE | 40MG | TABLET | Actual shortage | 2024-06-07 | 2024-06-13 | 229936 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-03-17 | 2017-04-25 | 3124 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-05-23 | 2017-09-19 | 10889 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2018-03-13 | 2018-07-30 | 42588 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2018-03-16 | 2018-07-30 | 43152 |
TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2020-04-02 | 2020-05-01 | 110694 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118915 |
TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2020-07-30 | 2020-09-17 | 121506 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-09-03 | 2020-10-01 | 123729 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2020-10-01 | 2020-10-30 | 125494 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |